mpreda
Joined 10 years ago
Joined 10 years ago
It is also a concise statement that is trivial to verify.
(by "trivial" meaning much much easier to verify than to discover in the first place)
Never getting sick is an enabler to reaching the goal. And the goal is..?
Well.. Hippos is greek for horse, and Hippopotamus is a "river horse". Same for Hippodrome, a course for horses. And in latin, hypo means small (and not large), as seen in e.g. hypoglycemia.
Those in addition to what it already has: 1 month battery life, HR and SpO2 tracking, flashlight.
Also, blood glocose and BHB monitoring would be nice.
And I didn't mention the software..
The article itself raises the issue of "lack of clinical data", given that these substances are relativelly new. But the lack of data may originate from a certain stiffness, or lack of accessibility and high cost of clinical trials. An alternative source of information are these people who self-experiment, but unfortunatelly this information is mostly lost instead of being captured.
How could this proposal work in practice? clearly the data would be noisy, contain some false reporting, biased, subjective etc. But statistical processing of a large number of reports (coming from hudreds of thousands or millions of self-reporting subjects) may still extract relevant scientific information; that we're dropping on the floor right now.
An example: I'm experimenting with a radical diet. I keep observations for myself, but they're not shared with anybody and don't contribute to science.
What the altervative would be: I would enroll on a web page, where I would describe the experiment I plan to do before I start it. I would be get a code for a blood/urine work for the "before" state, with the agreement that the results, anonimized, are shared with the platform. Weekly I would report on the platform observations, such as: got sick in this particular way, wheight variations, sleep eval, or any other changes.
At the end, or periodically I would get new free blood/urine work with the results shared.
Research institutes and pharma would get access to the data, to aggregate and denoise as they can to extract the latent information.
I don't understand, who's holding that "foreign held debt"? foreign countries I suppose, so which countries do you have in mind?
For one, it's not China, which holds a large amount of US treasury bonds (so basically, China is a lender of USD). So the revaluation of USD would work great for China: one, the value of the China-held USD bonds increases, and second, the price of Chinese exports decreases in USD terms.
So help me understand, what's the plan with the revaluation of USD?
Soon to be "Numerals of America"
1. "Lord of Light" by Roger Zelazny